# Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke

> **NCT00639249** · PHASE2 · COMPLETED · sponsor: **M's Science Corporation** · enrollment: 60 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** placebo
- **DRUG:** SA4503 Low
- **DRUG:** SA4503 High

## Key facts

- **NCT ID:** NCT00639249
- **Lead sponsor:** M's Science Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-06
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2009-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639249, "Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00639249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*